Kevin Johnston
Chief Tech/Sci/R&D Officer at CULLINAN THERAPEUTICS, INC.
Kevin Johnston active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-04-30 | - |
Career history of Kevin Johnston
Former positions of Kevin Johnston
| Companies | Position | Start | End |
|---|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2020-05-31 | 2022-03-31 |
| TESARO INC | Corporate Officer/Principal | 2014-12-31 | 2020-04-30 |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2022-04-30 | - |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
Charles River Laboratories Edinburgh Ltd.
 Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Charles River Laboratories Edinburgh Ltd. provides drug development services. The company is headquartered in Tranent, the United Kingdom. | Corporate Officer/Principal | - | - |
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 2006-12-31 | - |
Training of Kevin Johnston
| Northeastern University | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Charles River Laboratories Edinburgh Ltd.
Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Charles River Laboratories Edinburgh Ltd. provides drug development services. The company is headquartered in Tranent, the United Kingdom. | Health Technology |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Stock Market
- Insiders
- Kevin Johnston
- Experience